Stock Events

Stock Events

Journey Medical 

$6.56
13
+$0.10+1.55% 19:47 Today

Statistics

Day High
6.74
Day Low
6.44
52W High
9.56
52W Low
4.31
Volume
171,450
Avg. Volume
257,461
Mkt Cap
180.63M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.24
-0.12
-0.01
0.1
Expected EPS
0.015
Actual EPS
N/A

Financials

-18.48%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
61.86MRevenue
-11.43MNet Income

Analyst Ratings

14.00Average Price Target
The highest estimate is 15.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DERM. It's not an investment recommendation.
Apple
5
AAPL
Coca-Cola
5
KO
Gamestop
5
GME
Microsoft
4
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its Janssen Pharmaceuticals segment, develops treatments for various dermatological conditions, directly competing with Journey Medical.
Merck
MRK
Mkt Cap335.14B
Merck & Co., Inc. provides medications and vaccines for various conditions, including dermatological diseases, competing with Journey Medical's offerings.
Pfizer
PFE
Mkt Cap152.69B
Pfizer Inc. has a diverse range of healthcare products, including treatments for skin conditions that compete with Journey Medical's dermatology products.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline plc offers a variety of prescription medicines and vaccines, some of which are for dermatological conditions, making it a competitor.
Novartis
NVS
Mkt Cap286.78B
Novartis AG, through its Sandoz division, offers generic and biosimilar dermatology products, competing in the same market as Journey Medical.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc., with its acquisition of Allergan, has a strong dermatology portfolio that competes with Journey Medical's dermatological treatments.
AMGEN
AMGN
Mkt Cap224.63B
Amgen Inc. develops biologic medicines for various conditions, including psoriasis, a key area of competition with Journey Medical.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb offers treatments for a range of diseases, including skin conditions, competing with Journey Medical's dermatology focus.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals, Inc. is known for its innovative treatments in dermatology, including eczema, directly competing with Journey Medical.

About

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Show more...
CEO
Claude Maraoui
Employees
58
Country
United States
ISIN
US48115J1097

Listings

BOATS
BOATS
DERM.BOATS
XNAS
US
DERM

0 Comments

Share your thoughts

FAQ

What is Journey Medical stock price today?▼
The current price of DERM is $6.56 USD — it has increased by +1.55% in the past 24 hours. Watch Journey Medical stock price performance more closely on the chart.
What is Journey Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Journey Medical stocks are traded under the ticker DERM.
Is Journey Medical stock price growing?▼
DERM stock has risen by +4.19% compared to the previous week, the month change is a -8.03% fall, over the last year Journey Medical has showed a -5.93% decrease.
What is Journey Medical market cap?▼
Today Journey Medical has the market capitalization of 180.63M
When is the next Journey Medical earnings date?▼
Journey Medical is going to release the next earnings report on November 11, 2026.
What were Journey Medical earnings last quarter?▼
DERM earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.02 USD resulting in a +55.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Journey Medical revenue for the last year?▼
Journey Medical revenue for the last year amounts to 61.86M USD.
What is Journey Medical net income for the last year?▼
DERM net income for the last year is -11.43M USD.
How many employees does Journey Medical have?▼
As of August 18, 2026, the company has 58 employees.
In which sector is Journey Medical located?▼
Journey Medical operates in the Health & Wellness sector.
When did Journey Medical complete a stock split?▼
Journey Medical has not had any recent stock splits.
Where is Journey Medical headquartered?▼
Journey Medical is headquartered in SCOTTSDALE, United States.